METTL3 and acute myeloid leukemia: By performing two independent CRISPR screens, Barbieri et al. showed that METTL3 was necessary for AML cell survival and further revealed that the CAATT-box-binding protein CEBPZ was required for recruitment of METTL3 to chromatin.